These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effect of crocin on experimental atherosclerosis in quails and its mechanisms. He SY; Qian ZY; Tang FT; Wen N; Xu GL; Sheng L Life Sci; 2005 Jul; 77(8):907-21. PubMed ID: 15964309 [TBL] [Abstract][Full Text] [Related]
26. Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration. Zhao B; Luo X; Shi H; Ma D Thromb Res; 2011 Aug; 128(2):179-85. PubMed ID: 21458846 [TBL] [Abstract][Full Text] [Related]
27. Hyperlipemic-very low density lipoprotein, intermediate density lipoprotein and low density lipoprotein act synergistically with serotonin on vascular smooth muscle cell proliferation. Koba S; Pakala R; Katagiri T; Benedict CR Atherosclerosis; 2000 Mar; 149(1):61-7. PubMed ID: 10704615 [TBL] [Abstract][Full Text] [Related]
28. Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins. Argmann CA; Sawyez CG; Li S; Nong Z; Hegele RA; Pickering JG; Huff MW Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1290-6. PubMed ID: 15130914 [TBL] [Abstract][Full Text] [Related]
29. The effects of low density lipoproteins modified by incubation with chondroitin 6-sulfate on human aortic smooth muscle cells. Tîrziu D; Jinga VV; Serban G; Simionescu M Atherosclerosis; 1999 Nov; 147(1):155-66. PubMed ID: 10525137 [TBL] [Abstract][Full Text] [Related]
30. Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells. Bochkov VN; Tkachuk VA; Kuzmenko YS; Borisova YL; Bühler FR; Resink TJ Mol Pharmacol; 1994 Feb; 45(2):262-70. PubMed ID: 8114675 [TBL] [Abstract][Full Text] [Related]
34. Low-density lipoprotein-induced formation of nitric oxide by cultured vascular smooth muscle cells of the rat. Locher R; Suter PM; Weisser B; Vetter W Eur J Clin Invest; 1997 Jul; 27(7):603-10. PubMed ID: 9263749 [TBL] [Abstract][Full Text] [Related]
35. Proliferative effects of low-density lipoprotein subfractions on vascular smooth muscle cells: potentiation by insulin. Weisser B; Locher R; Lehmann E; de Graaf J; Vetter W J Hypertens Suppl; 1993 Dec; 11(5):S126-7. PubMed ID: 8158307 [No Abstract] [Full Text] [Related]
36. [Green tea polyphenols inhibit low-density lipoprotein-induced proliferation of rat vascular smooth muscle cells]. Ouyang P; Peng WL; Lai WY; Xu AL Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):975-9. PubMed ID: 15447839 [TBL] [Abstract][Full Text] [Related]
37. Stimulation of smooth muscle cell proliferation by ox-LDL- and acetyl LDL-induced macrophage-derived foam cells. Shen CM; Mao SJ; Huang GS; Yang PC; Chu RM Life Sci; 2001 Dec; 70(4):443-52. PubMed ID: 11798013 [TBL] [Abstract][Full Text] [Related]
38. Effect of low density lipoprotein on glycosaminoglycan secretion by cultured human smooth muscle cells and fibroblasts. Influence of serum concentration and cell proliferation rate. Wosu L; Parisella R; Kalant N Atherosclerosis; 1983 Sep; 48(3):205-20. PubMed ID: 6639705 [TBL] [Abstract][Full Text] [Related]
39. Novel cellular activities for low density lipoprotein in vascular smooth muscle cells. Sachinidis A; Mengden T; Locher R; Brunner C; Vetter W Hypertension; 1990 Jun; 15(6 Pt 2):704-11. PubMed ID: 2351425 [TBL] [Abstract][Full Text] [Related]
40. The influence of platelet-smooth muscle cell interaction on the oxidative modification of low-density lipoprotein. Alexander JJ; Lewis I J Surg Res; 2002 Mar; 103(1):41-6. PubMed ID: 11855916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]